JGIA
NVO

Jackson Grant Investment Advisers’s Novo Nordisk NVO Stock Holding History

Jackson Grant Investment Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9K Hold
561
– – 0.01% 236
2026
Q1 		$20.6K Hold
561
– – 0.01% 258
2025
Q4 		$28.5K Buy
+561
New +$28.7K 0.01% 235

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Jackson Grant Investment Advisers's NVO Position: Q2 2026 in Review

Jackson Grant Investment Advisers held its Novo Nordisk (NVO) position steady in Q2 2026 at 561 shares worth $26.9K. The position accounts for 0.01% of the portfolio, ranked #236.

Jackson Grant Investment Advisers first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $28.5K in Q4 2025. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Jackson Grant Investment Advisers held 561 shares of Novo Nordisk worth $26.9K as of Q2 2026.
  • Jackson Grant Investment Advisers left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #236 holding.
  • Jackson Grant Investment Advisers first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • Jackson Grant Investment Advisers's Novo Nordisk position peaked at $28.5K in Q4 2025.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.